IP Verse

Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters - EP3280416B1

PatentPatent Analysis

EP3280416

JANSSEN PHARMACEUTICA
Application Number
EP16777058A
Filing Date
Mar 30, 2016
Status
Granted And Under Opposition
Mar 20, 2020
Grant Date
Apr 22, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2234617B2
EP4005555B1
EP4025188B1

Bibliography

The patent EP3280416B1 was granted to Janssen Pharmaceutica on Apr 22, 2020 following the initial filing on Mar 30, 2016 under the application number EP16777058A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBJan 22, 2021ADMISSIBLE
HOFFMANN EITLEJan 22, 2021ADMISSIBLE
STADA ARZNEIMITTELJan 22, 2021ADMISSIBLE
ACCORD HEALTHCAREJan 21, 2021ADMISSIBLE
HEXALJan 21, 2021ADMISSIBLE
TEVA PHARMACEUTICALSJan 21, 2021ADMISSIBLE
HAMM & WITTKOPPJan 19, 2021WITHDRAWN
INSTONEDec 1, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents